HEADER OXIDOREDUCTASE 20-AUG-12 4B7K TITLE FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH CONSENSUS ANKYRIN REPEAT TITLE 2 DOMAIN-SER PEPTIDE (20-MER) COMPND MOL_ID: 1; COMPND 2 MOLECULE: HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: FACTOR INHIBITING HIF, FACTOR INHIBITING HIF-1, FIH-1, COMPND 5 HYPOXIA-INDUCIBLE FACTOR ASPARAGINE HYDROXYLASE; COMPND 6 EC: 1.14.11.16, 1.14.11.30; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: CONSENSUS ANKYRIN REPEAT DOMAIN-SER; COMPND 10 CHAIN: B; COMPND 11 ENGINEERED: YES; COMPND 12 OTHER_DETAILS: SYNTHETIC PEPTIDE (20-MER) SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET28A; SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES; SOURCE 12 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 13 ORGANISM_TAXID: 32630 KEYWDS OXIDOREDUCTASE, NON-HEME, IRON, 2-OXOGLUTARATE, DIOXYGENASE, HYPOXIA, KEYWDS 2 DNA-BINDING, METAL-BINDING, TRANSCRIPTION, HELIX-LOOP-TRANSCRIPTION, KEYWDS 3 HELIX-LOOP-HELIX-BETA, DSBH, FACIAL TRIAD, HELIX-BETA, ASPARAGINYL/ KEYWDS 4 ASPARTYL HYDROXYLASE, TRANSCRIPTION AND EPIGENETIC REGULATION, KEYWDS 5 SIGNALING, DEVELOPMENT, ANKYRIN REPEAT DOMAIN, ARD, BETA- KEYWDS 6 HYDROXYLATION, TRANSCRIPTION ACTIVATOR/INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR R.CHOWDHURY,W.GE,C.J.SCHOFIELD REVDAT 4 20-DEC-23 4B7K 1 REMARK LINK REVDAT 3 28-MAR-18 4B7K 1 JRNL REVDAT 2 20-FEB-13 4B7K 1 JRNL REVDAT 1 23-JAN-13 4B7K 0 JRNL AUTH M.YANG,A.P.HARDY,R.CHOWDHURY,N.D.LOIK,J.S.SCOTTI, JRNL AUTH 2 J.S.MCCULLAGH,T.D.CLARIDGE,M.A.MCDONOUGH,W.GE,C.J.SCHOFIELD JRNL TITL SUBSTRATE SELECTIVITY ANALYSES OF FACTOR INHIBITING JRNL TITL 2 HYPOXIA-INDUCIBLE FACTOR. JRNL REF ANGEW. CHEM. INT. ED. ENGL. V. 52 1700 2013 JRNL REFN ESSN 1521-3773 JRNL PMID 23296631 JRNL DOI 10.1002/ANIE.201208046 REMARK 2 REMARK 2 RESOLUTION. 2.39 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.3 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.39 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.91 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 206123.270 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 22918 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.225 REMARK 3 FREE R VALUE : 0.241 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 1192 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 13 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.39 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.45 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1518 REMARK 3 BIN R VALUE (WORKING SET) : 0.3470 REMARK 3 BIN FREE R VALUE : 0.3330 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.80 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 78 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.029 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2836 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 31 REMARK 3 SOLVENT ATOMS : 84 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 45.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 61.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.31000 REMARK 3 B22 (A**2) : -3.31000 REMARK 3 B33 (A**2) : 6.62000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.35 REMARK 3 ESD FROM SIGMAA (A) : 0.39 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.37 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.38 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.050 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.170 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.950 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 4.030 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.300 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 53.45 REMARK 3 REMARK 3 NCS MODEL : NONE REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : OGA.PAR REMARK 3 PARAMETER FILE 5 : GOL.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : OGA.TOP REMARK 3 TOPOLOGY FILE 5 : GOL.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 4B7K COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-AUG-12. REMARK 100 THE DEPOSITION ID IS D_1290053804. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-DEC-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97940 REMARK 200 MONOCHROMATOR : SI 111 REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22918 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.390 REMARK 200 RESOLUTION RANGE LOW (A) : 29.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 12.00 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 17.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.39 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.45 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.7 REMARK 200 DATA REDUNDANCY IN SHELL : 9.00 REMARK 200 R MERGE FOR SHELL (I) : 0.53000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1H2K REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.08 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.6 M AMMONIUM SULPHATE, 6% PEG 400, REMARK 280 0.1 M HEPES PH 7.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 74.15400 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 43.17750 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 43.17750 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 37.07700 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 43.17750 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 43.17750 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 111.23100 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 43.17750 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 43.17750 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 37.07700 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 43.17750 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 43.17750 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 111.23100 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 74.15400 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9580 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 29820 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -224.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 86.35500 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 -86.35500 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ALA A 3 REMARK 465 THR A 4 REMARK 465 ALA A 5 REMARK 465 ALA A 6 REMARK 465 GLU A 7 REMARK 465 ALA A 8 REMARK 465 VAL A 9 REMARK 465 ALA A 10 REMARK 465 SER A 11 REMARK 465 HIS B 1 REMARK 465 LEU B 2 REMARK 465 GLU B 3 REMARK 465 ASP B 19 REMARK 465 LYS B 20 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 15 CG CD OE1 OE2 REMARK 470 GLU A 29 CG CD OE1 OE2 REMARK 470 ARG A 40 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 115 CG CD CE NZ REMARK 470 ARG A 117 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 156 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 250 CD OE1 OE2 REMARK 470 ARG A 305 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 307 CG CD OE1 OE2 REMARK 470 VAL B 4 CG1 CG2 REMARK 470 LYS B 6 CG CD CE NZ REMARK 470 GLU B 10 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 29 -38.18 -35.29 REMARK 500 THR A 153 25.36 -77.30 REMARK 500 ARG A 238 3.98 83.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 501 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 199 NE2 REMARK 620 2 ASP A 201 OD2 119.3 REMARK 620 3 HIS A 279 NE2 83.2 84.6 REMARK 620 4 OGA A 601 O2' 85.3 155.3 97.8 REMARK 620 5 OGA A 601 O2 159.3 77.9 87.4 77.7 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OGA A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 902 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 904 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 905 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1H2K RELATED DB: PDB REMARK 900 FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH HIF-1 ALPHA FRAGMENT REMARK 900 PEPTIDE REMARK 900 RELATED ID: 1H2L RELATED DB: PDB REMARK 900 FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH HIF-1 ALPHA FRAGMENT REMARK 900 PEPTIDE REMARK 900 RELATED ID: 1H2M RELATED DB: PDB REMARK 900 FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH HIF-1 ALPHA FRAGMENT REMARK 900 PEPTIDE REMARK 900 RELATED ID: 1H2N RELATED DB: PDB REMARK 900 FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH HIF-1 ALPHA FRAGMENT REMARK 900 PEPTIDE REMARK 900 RELATED ID: 1IZ3 RELATED DB: PDB REMARK 900 DIMERIC STRUCTURE OF FIH (FACTOR INHIBITING HIF) REMARK 900 RELATED ID: 1MZE RELATED DB: PDB REMARK 900 HUMAN FACTOR INHIBITING HIF (FIH1) REMARK 900 RELATED ID: 1MZF RELATED DB: PDB REMARK 900 HUMAN FACTOR INHIBITING HIF (FIH1) IN COMPLEX WITH 2- OXOGLUTARATE REMARK 900 RELATED ID: 1YCI RELATED DB: PDB REMARK 900 FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH N-( CARBOXYCARBONYL)- REMARK 900 D-PHENYLALANINE REMARK 900 RELATED ID: 2CGN RELATED DB: PDB REMARK 900 FACTOR INHIBITING HIF-1 ALPHA WITH SUCCINATE REMARK 900 RELATED ID: 2CGO RELATED DB: PDB REMARK 900 FACTOR INHIBITING HIF-1 ALPHA WITH FUMARATE REMARK 900 RELATED ID: 2W0X RELATED DB: PDB REMARK 900 FACTOR INHIBITING HIF-1 ALPHA WITH PYRIDINE 2,4 DICARBOXYLIC ACID REMARK 900 RELATED ID: 2WA3 RELATED DB: PDB REMARK 900 FACTOR INHIBITING HIF-1 ALPHA WITH 2-(3-HYDROXYPHENYL )-2-OXOACETIC REMARK 900 ACID REMARK 900 RELATED ID: 2WA4 RELATED DB: PDB REMARK 900 FACTOR INHIBITING HIF-1 ALPHA WITH N,3- DIHYDROXYBENZAMIDE REMARK 900 RELATED ID: 2XUM RELATED DB: PDB REMARK 900 FACTOR INHIBITING HIF (FIH) Q239H MUTANT IN COMPLEX WITH ZN(II), REMARK 900 NOG AND ASP-SUBSTRATE PEPTIDE (20-MER) REMARK 900 RELATED ID: 2Y0I RELATED DB: PDB REMARK 900 FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH TANKYRASE-2 (TNKS2) REMARK 900 FRAGMENT PEPTIDE (21-MER) REMARK 900 RELATED ID: 2YC0 RELATED DB: PDB REMARK 900 FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH R-2- HYDROXYGLUTARATE REMARK 900 RELATED ID: 2YDE RELATED DB: PDB REMARK 900 FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH S-2- HYDROXYGLUTARATE REMARK 900 RELATED ID: 4AI8 RELATED DB: PDB REMARK 900 FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH DAMINOZIDE REMARK 900 RELATED ID: 4B7E RELATED DB: PDB REMARK 900 FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH CONSENSUS ANKYRIN REMARK 900 REPEAT DOMAIN-LEU PEPTIDE (20-MER) DBREF 4B7K A 1 349 UNP Q9NWT6 HIF1N_HUMAN 1 349 DBREF 4B7K B 1 20 PDB 4B7K 4B7K 1 20 SEQRES 1 A 349 MET ALA ALA THR ALA ALA GLU ALA VAL ALA SER GLY SER SEQRES 2 A 349 GLY GLU PRO ARG GLU GLU ALA GLY ALA LEU GLY PRO ALA SEQRES 3 A 349 TRP ASP GLU SER GLN LEU ARG SER TYR SER PHE PRO THR SEQRES 4 A 349 ARG PRO ILE PRO ARG LEU SER GLN SER ASP PRO ARG ALA SEQRES 5 A 349 GLU GLU LEU ILE GLU ASN GLU GLU PRO VAL VAL LEU THR SEQRES 6 A 349 ASP THR ASN LEU VAL TYR PRO ALA LEU LYS TRP ASP LEU SEQRES 7 A 349 GLU TYR LEU GLN GLU ASN ILE GLY ASN GLY ASP PHE SER SEQRES 8 A 349 VAL TYR SER ALA SER THR HIS LYS PHE LEU TYR TYR ASP SEQRES 9 A 349 GLU LYS LYS MET ALA ASN PHE GLN ASN PHE LYS PRO ARG SEQRES 10 A 349 SER ASN ARG GLU GLU MET LYS PHE HIS GLU PHE VAL GLU SEQRES 11 A 349 LYS LEU GLN ASP ILE GLN GLN ARG GLY GLY GLU GLU ARG SEQRES 12 A 349 LEU TYR LEU GLN GLN THR LEU ASN ASP THR VAL GLY ARG SEQRES 13 A 349 LYS ILE VAL MET ASP PHE LEU GLY PHE ASN TRP ASN TRP SEQRES 14 A 349 ILE ASN LYS GLN GLN GLY LYS ARG GLY TRP GLY GLN LEU SEQRES 15 A 349 THR SER ASN LEU LEU LEU ILE GLY MET GLU GLY ASN VAL SEQRES 16 A 349 THR PRO ALA HIS TYR ASP GLU GLN GLN ASN PHE PHE ALA SEQRES 17 A 349 GLN ILE LYS GLY TYR LYS ARG CYS ILE LEU PHE PRO PRO SEQRES 18 A 349 ASP GLN PHE GLU CYS LEU TYR PRO TYR PRO VAL HIS HIS SEQRES 19 A 349 PRO CYS ASP ARG GLN SER GLN VAL ASP PHE ASP ASN PRO SEQRES 20 A 349 ASP TYR GLU ARG PHE PRO ASN PHE GLN ASN VAL VAL GLY SEQRES 21 A 349 TYR GLU THR VAL VAL GLY PRO GLY ASP VAL LEU TYR ILE SEQRES 22 A 349 PRO MET TYR TRP TRP HIS HIS ILE GLU SER LEU LEU ASN SEQRES 23 A 349 GLY GLY ILE THR ILE THR VAL ASN PHE TRP TYR LYS GLY SEQRES 24 A 349 ALA PRO THR PRO LYS ARG ILE GLU TYR PRO LEU LYS ALA SEQRES 25 A 349 HIS GLN LYS VAL ALA ILE MET ARG ASN ILE GLU LYS MET SEQRES 26 A 349 LEU GLY GLU ALA LEU GLY ASN PRO GLN GLU VAL GLY PRO SEQRES 27 A 349 LEU LEU ASN THR MET ILE LYS GLY ARG TYR ASN SEQRES 1 B 20 HIS LEU GLU VAL VAL LYS LEU LEU LEU GLU HIS GLY ALA SEQRES 2 B 20 ASP VAL SER ALA GLN ASP LYS HET ZN A 501 1 HET OGA A 601 10 HET SO4 A 901 5 HET SO4 A 902 5 HET SO4 A 904 5 HET SO4 A 905 5 HETNAM ZN ZINC ION HETNAM OGA N-OXALYLGLYCINE HETNAM SO4 SULFATE ION FORMUL 3 ZN ZN 2+ FORMUL 4 OGA C4 H5 N O5 FORMUL 5 SO4 4(O4 S 2-) FORMUL 9 HOH *84(H2 O) HELIX 1 1 ASP A 28 LEU A 32 5 5 HELIX 2 2 ASP A 49 ASN A 58 1 10 HELIX 3 3 VAL A 70 TRP A 76 5 7 HELIX 4 4 ASP A 77 ILE A 85 1 9 HELIX 5 5 ASP A 104 MET A 108 5 5 HELIX 6 6 LYS A 124 ARG A 138 1 15 HELIX 7 7 GLY A 155 LEU A 163 1 9 HELIX 8 8 ASN A 166 GLY A 178 1 13 HELIX 9 9 PRO A 220 ASP A 222 5 3 HELIX 10 10 GLN A 223 TYR A 228 1 6 HELIX 11 11 PHE A 252 VAL A 258 5 7 HELIX 12 12 LYS A 311 LEU A 330 1 20 HELIX 13 13 ASN A 332 GLN A 334 5 3 HELIX 14 14 GLU A 335 LYS A 345 1 11 HELIX 15 15 VAL B 4 GLU B 10 1 7 SHEET 1 AA 5 THR A 39 PRO A 41 0 SHEET 2 AA 5 GLY A 260 VAL A 265 1 O GLY A 260 N ARG A 40 SHEET 3 AA 5 LYS A 214 PHE A 219 -1 O LYS A 214 N VAL A 265 SHEET 4 AA 5 TRP A 278 SER A 283 -1 O TRP A 278 N PHE A 219 SHEET 5 AA 5 VAL A 195 HIS A 199 -1 O THR A 196 N ILE A 281 SHEET 1 AB 9 ARG A 44 LEU A 45 0 SHEET 2 AB 9 VAL A 62 LEU A 64 1 O VAL A 63 N LEU A 45 SHEET 3 AB 9 VAL A 270 ILE A 273 -1 O VAL A 270 N LEU A 64 SHEET 4 AB 9 GLN A 203 LYS A 211 -1 O ASN A 205 N ILE A 273 SHEET 5 AB 9 THR A 290 LYS A 298 -1 O ILE A 291 N ILE A 210 SHEET 6 AB 9 LEU A 186 GLY A 190 -1 O LEU A 186 N ASN A 294 SHEET 7 AB 9 ARG A 143 THR A 149 -1 O LEU A 146 N ILE A 189 SHEET 8 AB 9 VAL A 92 ALA A 95 -1 O TYR A 93 N TYR A 145 SHEET 9 AB 9 SER A 118 GLU A 121 -1 O ASN A 119 N SER A 94 SHEET 1 AC 6 ARG A 44 LEU A 45 0 SHEET 2 AC 6 VAL A 62 LEU A 64 1 O VAL A 63 N LEU A 45 SHEET 3 AC 6 VAL A 270 ILE A 273 -1 O VAL A 270 N LEU A 64 SHEET 4 AC 6 GLN A 203 LYS A 211 -1 O ASN A 205 N ILE A 273 SHEET 5 AC 6 THR A 290 LYS A 298 -1 O ILE A 291 N ILE A 210 SHEET 6 AC 6 LEU A 182 SER A 184 -1 N THR A 183 O TRP A 296 LINK NE2 HIS A 199 ZN ZN A 501 1555 1555 2.33 LINK OD2 ASP A 201 ZN ZN A 501 1555 1555 2.28 LINK NE2 HIS A 279 ZN ZN A 501 1555 1555 2.23 LINK ZN ZN A 501 O2' OGA A 601 1555 1555 2.15 LINK ZN ZN A 501 O2 OGA A 601 1555 1555 2.10 CISPEP 1 TYR A 308 PRO A 309 0 -2.37 SITE 1 AC1 5 HIS A 199 ASP A 201 HIS A 279 OGA A 601 SITE 2 AC1 5 SER B 16 SITE 1 AC2 12 TYR A 145 LEU A 188 THR A 196 HIS A 199 SITE 2 AC2 12 ASP A 201 ASN A 205 PHE A 207 LYS A 214 SITE 3 AC2 12 HIS A 279 ASN A 294 TRP A 296 ZN A 501 SITE 1 AC3 3 GLY A 140 GLU A 141 GLU A 142 SITE 1 AC4 4 LYS A 311 ALA A 312 HOH A2055 HOH A2076 SITE 1 AC5 5 ARG A 143 GLU A 192 GLY A 193 LEU A 285 SITE 2 AC5 5 ASN A 286 SITE 1 AC6 2 ARG A 17 ARG A 44 CRYST1 86.355 86.355 148.308 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011580 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011580 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006743 0.00000